Drugs in Dev.
Infections and Infectious Diseases
Phase IV
United Arab Emirates 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Favipiravir
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Appili Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Appili Therapeutics and AiPharma Announce Strategic Alliance and Equity Transaction
Details : The partnership between Appili and AiPharma will include the formation of a joint scientific committee to further coordinate clinical and regulatory activities for global development of Avigan®/Reeqonus™ (favipiravir), a broad-spectrum oral antiviral.
Product Name : Avigan
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 29, 2021
Lead Product(s) : Favipiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Appili Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
